Promoting Health? It's All In The Game

Gamification - turning boring, unpleasant but necessary tasks into an online game - is a new way of thinking that is gaining momentum among drugmakers and health campaigners.

US Stock Index Futures Signal Wednesday Weakness

Stock index futures pointed to a lower open on Wall Street on Wednesday, with futures for the S&P 500 down 0.6 percent, Dow Jones futures 0.3 percent weaker, and Nasdaq 100 futures off 0.5 percent at 04:54 a.m. EDT (0854 GMT).

GSK insists it best owner for Human Genome

Drugmaker GlaxoSmithKline said on Wednesday its $2.6 billion bid for long-time partner Human Genome Sciences was full and fair and it was the only obvious owner for the U.S. biotechnology firm.

Human Genome exploring options after rebuff of Glaxo

Human Genome Sciences Inc , which rebuffed an unsolicited $2.6 billion takeover bid by British drugmaker GlaxoSmithKline , said on Tuesday it was reviewing strategic alternatives, including the sale of the company.

GSK offers $13/share in unsolicited Human Genome bid

Human Genome Sciences Inc said on Thursday its long-time partner GlaxoSmithKline Plc had made an unsolicited proposal to buy it for $13.00 per share in cash, a move underscoring the rapid pace of deal-making in pharmaceuticals.

James Murdoch severs all ties with UK newspapers

James Murdoch has severed all ties with News Corp's British newspaper business, which is at the centre of multiple investigations over phone and computer hacking and bribery, according to regulatory filings.



GlaxoSmithKline To Inject £500M Into UK Manufacturing

Britain's largest drugmaker GlaxoSmithKline announced on Thursday plans to invest £500 million ($792 million) in local manufacturing operations, opening a facility in Scotland that is expected to create 1,000 jobs over the coming years.
IBTimes Logo

Stock futures signal higher open; Oracle eyed

Stock index futures pointed to a higher open on Wall Street on Wednesday, with futures for the S&P 500 up 0.4 percent, Dow Jones futures up 0.2 percent and Nasdaq 100 futures also up 0.2 percent at 5 a.m. E.D.T. (0900 GMT)
People are seen on beds in a room at the National Cancer Research Center within the Institute for Oncology and Radiology in Belgrade, October 6, 2009.

Common Medicines May Cut Cancer Drug Potency: Study

Many patients taking a widely prescribed class of oral cancer drugs are also using a variety of medications that could reduce the effectiveness of the cancer treatment or increase its toxic side effects, according to research by Medco Health Solutions Inc.
Tensions between European governments and large drug companies like Pfizer have been rising for several years as administrations across the region face the challenge of curbing the rising costs of healthcare in tough economic times. Governments are by far

Pfizer's Ian Read: Europe Is Undermining Drug Innovation

Europe is undermining drug innovation by cutting prices, raising barriers to new medicines and freeloading off others in Asia and the United States who are more willing to pay, the boss of Pfizer, the world's largest drugmaker, said.